2023 Highlights

A few notable highlights as we reflect:

• 20+ published manuscripts, including 2 featured as editor’s choice with a corresponding editorial

  • Healthcare resource utilization and costs among patients with post-stroke spasticity before and after spasticity management including onabotulinumtoxina

• Has the Centers for Medicare & Medicaid Services Implicitly Adopted a Value Framework for Medicare Drug Price Negotiations?

• A study co-authored by Sean D. Sullivan, BSPharm, PhD, Professor at the University of Washington School of Pharmacy, CHOICE Institute and President of Curta was the recipient of a $25,000 prize by the PhRMA foundation. This award was one of three manuscript selected that explore crucial challenges facing the CMS in implementing Medicare drug price negotiation.

• Medicare Drug Price Negotiation: The Complexities of Selecting Therapeutic Alternatives for Estimating Comparative Effectiveness

• Presence at ISPOR International and ISPOR EU

• Thanks to all who joined us for our Austrian wine tasting, wine & cheese, and pub crawl events!

• Speaker participation in multiple issue panels and workshops, including RWE and Medicare IRA

• 8 new faces joined our team, listed in no particular order: Nikolina Boscovic, Adam Kasle, Yilin Chen, Noemi Brennan, Abigail Jarzin, Sarah Katsandres, Cynthia Gong, and Amy Tung

• Successful release of 4 Curta on Call issues

• What is the Shelf Life of a Model?

• Cost-Effectiveness Analysis: How Should We Deal With Skeptics?

• Searching for Orphans in Haystacks: A Real World Data Dilemma

• QALY Bashing: The Sequels

• All-company in-person retreat in Bend, Oregon

• Entered into a collaboration with the Peterson Health Technology Institute (PHTI) to conduct evidence-based assessments of the clinical benefits and economic impact of digital health solutions